Catalyst Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 39 U.S.-traded ETFs. CPRX has around 10.0M shares in the U.S. ETF market. The largest ETF holder of CPRX is the SPDR S&P Biotech ETF (XBI), with approximately 4.71M shares. Investors may also find of interest that the ETF with the largest allocation to CPRX stock is SPDR S&P Biotech ETF (XBI), with a portfolio weight of 0.42%. On average, U.S. ETFs allocate 0.09% of CPRX to their portfolios.
Additionally, CPRX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CPRX as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 29.93%.